Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study

Abstract Background Earlier epidemiological studies indicate that associations between obesity and breast cancer risk may not only depend on menopausal status and use of exogenous hormones, but might also differ by tumor subtype. Here, we evaluated whether obesity is differentially associated with t...

Full description

Bibliographic Details
Main Authors: Cina J. Nattenmüller, Mark Kriegsmann, Disorn Sookthai, Renée Turzanski Fortner, Annika Steffen, Britta Walter, Theron Johnson, Jutta Kneisel, Verena Katzke, Manuela Bergmann, Hans Peter Sinn, Peter Schirmacher, Esther Herpel, Heiner Boeing, Rudolf Kaaks, Tilman Kühn
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-4548-6
_version_ 1818291941813518336
author Cina J. Nattenmüller
Mark Kriegsmann
Disorn Sookthai
Renée Turzanski Fortner
Annika Steffen
Britta Walter
Theron Johnson
Jutta Kneisel
Verena Katzke
Manuela Bergmann
Hans Peter Sinn
Peter Schirmacher
Esther Herpel
Heiner Boeing
Rudolf Kaaks
Tilman Kühn
author_facet Cina J. Nattenmüller
Mark Kriegsmann
Disorn Sookthai
Renée Turzanski Fortner
Annika Steffen
Britta Walter
Theron Johnson
Jutta Kneisel
Verena Katzke
Manuela Bergmann
Hans Peter Sinn
Peter Schirmacher
Esther Herpel
Heiner Boeing
Rudolf Kaaks
Tilman Kühn
author_sort Cina J. Nattenmüller
collection DOAJ
description Abstract Background Earlier epidemiological studies indicate that associations between obesity and breast cancer risk may not only depend on menopausal status and use of exogenous hormones, but might also differ by tumor subtype. Here, we evaluated whether obesity is differentially associated with the risk of breast tumor subtypes, as defined by 6 immunohistochemical markers (ER, PR, HER2, Ki67, Bcl-2 and p53, separately and combined), in the prospective EPIC-Germany Study (n = 27,012). Methods Formalin-fixed and paraffin-embedded (FFPE) tumor tissues of 657 incident breast cancer cases were used for histopathological analyses. Associations between BMI and breast cancer risk across subtypes were evaluated by multivariable Cox regression models stratified by menopausal status and hormone therapy (HT) use. Results Among postmenopausal non-users of HT, higher BMI was significantly associated with an increased risk of less aggressive, i.e. ER+, PR+, HER2-, Ki67low, Bcl-2+ and p53- tumors (HR per 5 kg/m2: 1.44 [1.10, 1.90], p = 0.009), but not with risk of more aggressive tumor subtypes. Among postmenopausal users of HT, BMI was significantly inversely associated with less aggressive tumors (HR per 5 kg/m2: 0.68 [0.50, 0.94], p = 0.018). Finally, among pre- and perimenopausal women, Cox regression models did not reveal significant linear associations between BMI and risk of any tumor subtype, although analyses by BMI tertiles showed a significantly lower risk of less aggressive tumors for women in the highest tertile (HR: 0.55 [0.33, 0.93]). Conclusion Overall, our results suggest that obesity is related to risk of breast tumors with lower aggressiveness, a finding that requires replication in larger-scale analyses of pooled prospective data.
first_indexed 2024-12-13T02:52:04Z
format Article
id doaj.art-078d95219a714ca8bdaa74c1ed66d2e3
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-13T02:52:04Z
publishDate 2018-05-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-078d95219a714ca8bdaa74c1ed66d2e32022-12-22T00:02:02ZengBMCBMC Cancer1471-24072018-05-011811810.1186/s12885-018-4548-6Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort studyCina J. Nattenmüller0Mark Kriegsmann1Disorn Sookthai2Renée Turzanski Fortner3Annika Steffen4Britta Walter5Theron Johnson6Jutta Kneisel7Verena Katzke8Manuela Bergmann9Hans Peter Sinn10Peter Schirmacher11Esther Herpel12Heiner Boeing13Rudolf Kaaks14Tilman Kühn15Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)Institute of Pathology, University Hospital HeidelbergDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ)Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)Department of Epidemiology, German Institute of Human Nutrition (DIfE) Postdam-RehbrückeInstitute of Pathology, University Hospital HeidelbergDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ)Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)Department of Epidemiology, German Institute of Human Nutrition (DIfE) Postdam-RehbrückeInstitute of Pathology, University Hospital HeidelbergInstitute of Pathology, University Hospital HeidelbergInstitute of Pathology, University Hospital HeidelbergDepartment of Epidemiology, German Institute of Human Nutrition (DIfE) Postdam-RehbrückeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ)Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)Abstract Background Earlier epidemiological studies indicate that associations between obesity and breast cancer risk may not only depend on menopausal status and use of exogenous hormones, but might also differ by tumor subtype. Here, we evaluated whether obesity is differentially associated with the risk of breast tumor subtypes, as defined by 6 immunohistochemical markers (ER, PR, HER2, Ki67, Bcl-2 and p53, separately and combined), in the prospective EPIC-Germany Study (n = 27,012). Methods Formalin-fixed and paraffin-embedded (FFPE) tumor tissues of 657 incident breast cancer cases were used for histopathological analyses. Associations between BMI and breast cancer risk across subtypes were evaluated by multivariable Cox regression models stratified by menopausal status and hormone therapy (HT) use. Results Among postmenopausal non-users of HT, higher BMI was significantly associated with an increased risk of less aggressive, i.e. ER+, PR+, HER2-, Ki67low, Bcl-2+ and p53- tumors (HR per 5 kg/m2: 1.44 [1.10, 1.90], p = 0.009), but not with risk of more aggressive tumor subtypes. Among postmenopausal users of HT, BMI was significantly inversely associated with less aggressive tumors (HR per 5 kg/m2: 0.68 [0.50, 0.94], p = 0.018). Finally, among pre- and perimenopausal women, Cox regression models did not reveal significant linear associations between BMI and risk of any tumor subtype, although analyses by BMI tertiles showed a significantly lower risk of less aggressive tumors for women in the highest tertile (HR: 0.55 [0.33, 0.93]). Conclusion Overall, our results suggest that obesity is related to risk of breast tumors with lower aggressiveness, a finding that requires replication in larger-scale analyses of pooled prospective data.http://link.springer.com/article/10.1186/s12885-018-4548-6Breast cancerObesityTumor subtypesEstrogen receptorKi-67p53
spellingShingle Cina J. Nattenmüller
Mark Kriegsmann
Disorn Sookthai
Renée Turzanski Fortner
Annika Steffen
Britta Walter
Theron Johnson
Jutta Kneisel
Verena Katzke
Manuela Bergmann
Hans Peter Sinn
Peter Schirmacher
Esther Herpel
Heiner Boeing
Rudolf Kaaks
Tilman Kühn
Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
BMC Cancer
Breast cancer
Obesity
Tumor subtypes
Estrogen receptor
Ki-67
p53
title Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
title_full Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
title_fullStr Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
title_full_unstemmed Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
title_short Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
title_sort obesity as risk factor for subtypes of breast cancer results from a prospective cohort study
topic Breast cancer
Obesity
Tumor subtypes
Estrogen receptor
Ki-67
p53
url http://link.springer.com/article/10.1186/s12885-018-4548-6
work_keys_str_mv AT cinajnattenmuller obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT markkriegsmann obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT disornsookthai obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT reneeturzanskifortner obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT annikasteffen obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT brittawalter obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT theronjohnson obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT juttakneisel obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT verenakatzke obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT manuelabergmann obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT hanspetersinn obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT peterschirmacher obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT estherherpel obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT heinerboeing obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT rudolfkaaks obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy
AT tilmankuhn obesityasriskfactorforsubtypesofbreastcancerresultsfromaprospectivecohortstudy